116 related articles for article (PubMed ID: 10092198)
1. Studies on time-kill kinetics of different classes of antibiotics against veterinary pathogenic bacteria including Pasteurella, Actinobacillus and Escherichia coli.
Norcia LJ; Silvia AM; Hayashi SF
J Antibiot (Tokyo); 1999 Jan; 52(1):52-60. PubMed ID: 10092198
[TBL] [Abstract][Full Text] [Related]
2. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use.
Norcia LJ; Seibel SB; Kamicker BJ; Lemay MA; Lilley SC; Hecker SJ; Bergeron JM; Retsema JA; Hayashi SF
J Antibiot (Tokyo); 1998 Feb; 51(2):136-44. PubMed ID: 9544934
[TBL] [Abstract][Full Text] [Related]
3. In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens.
Norcia LJ; Silvia AM; Santoro SL; Retsema J; Letavic MA; Bronk BS; Lundy KM; Yang B; Evans NA; Hayashi SF
J Antibiot (Tokyo); 2004 Apr; 57(4):280-8. PubMed ID: 15217193
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.
de Jong A; Thomas V; Simjee S; Moyaert H; El Garch F; Maher K; Morrissey I; Butty P; Klein U; Marion H; Rigaut D; Vallé M
Vet Microbiol; 2014 Aug; 172(1-2):202-15. PubMed ID: 24837878
[TBL] [Abstract][Full Text] [Related]
5. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
Dorey L; Pelligand L; Lees P
BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin.
Prescott JF; Yielding KM
Can J Vet Res; 1990 Jan; 54(1):195-7. PubMed ID: 2306672
[TBL] [Abstract][Full Text] [Related]
7. Biofilm bacteria: formation and comparative susceptibility to antibiotics.
Olson ME; Ceri H; Morck DW; Buret AG; Read RR
Can J Vet Res; 2002 Apr; 66(2):86-92. PubMed ID: 11989739
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Resistance of
Siteavu MI; Drugea RI; Pitoiu E; Ciobotaru-Pirvu E
Microorganisms; 2023 Sep; 11(10):. PubMed ID: 37894069
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility and resistance of chicken Escherichia coli, Salmonella spp., and Pasteurella multocida isolates.
Huang TM; Lin TL; Wu CC
Avian Dis; 2009 Mar; 53(1):89-93. PubMed ID: 19432009
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs.
Raemdonck DL; Tanner AC; Tolling ST; Michener SL
Vet Rec; 1994 Jan; 134(1):5-7. PubMed ID: 8128570
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the multiple-drug efflux pump AcrAB in Escherichia coli prolongs the postantibiotic effect.
Stubbings W; Bostock J; Ingham E; Chopra I
Antimicrob Agents Chemother; 2005 Mar; 49(3):1206-8. PubMed ID: 15728929
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
Dayao D; Gibson JS; Blackall PJ; Turni C
Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of avian Escherichia coli and Pasteurella multocida to danofloxacin and five other antimicrobials.
Raemdonck DL; Tanner AC; Tolling ST; Michener SL
Avian Dis; 1992; 36(4):964-7. PubMed ID: 1336664
[TBL] [Abstract][Full Text] [Related]
14. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
Portis E; Lindeman C; Johansen L; Stoltman G
J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
Sweeney MT; Brumbaugh GW; Watts JL
Vet Ther; 2008; 9(3):212-22. PubMed ID: 19003782
[TBL] [Abstract][Full Text] [Related]
16. Short communication: Interaction of the isomers carvacrol and thymol with the antibiotics doxycycline and tilmicosin: In vitro effects against pathogenic bacteria commonly found in the respiratory tract of calves.
Kissels W; Wu X; Santos RR
J Dairy Sci; 2017 Feb; 100(2):970-974. PubMed ID: 28012625
[TBL] [Abstract][Full Text] [Related]
17. Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark.
Salmon SA; Watts JL; Case CA; Hoffman LJ; Wegener HC; Yancey RJ
J Clin Microbiol; 1995 Sep; 33(9):2435-44. PubMed ID: 7494042
[TBL] [Abstract][Full Text] [Related]
18. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
Shryock TR; Staples JM; DeRosa DC
J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of 12 antibiotics used in veterinary medicine against Mannheimia haemolytica and Pasteurella multocida isolated from calves in the Netherlands].
Mevius DJ; Hartman EG
Tijdschr Diergeneeskd; 2000 Mar; 125(5):147-52. PubMed ID: 10730339
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimicrobial susceptibility of Pasteurella haemolytica and Pasteurella multocida recovered from cattle with bovine respiratory disease complex.
Post KW; Cole NA; Raleigh RH
J Vet Diagn Invest; 1991 Apr; 3(2):124-6. PubMed ID: 1892929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
